Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer.

Fritz AJ, Gillis NE, Gerrard DL, Rodriguez PD, Hong D, Rose JT, Ghule PN, Bolf EL, Gordon JA, Tye CE, Boyd JR, Tracy KM, Nickerson JA, van Wijnen AJ, Imbalzano AN, Heath JL, Frietze SE, Zaidi SK, Carr FE, Lian JB, Stein JL, Stein GS.

Genes Chromosomes Cancer. 2019 Jul;58(7):484-499. doi: 10.1002/gcc.22731. Epub 2019 Mar 15. Review.

PMID:
30873710
2.

RUNX1-dependent mechanisms in biological control and dysregulation in cancer.

Hong D, Fritz AJ, Gordon JA, Tye CE, Boyd JR, Tracy KM, Frietze SE, Carr FE, Nickerson JA, Van Wijnen AJ, Imbalzano AN, Zaidi SK, Lian JB, Stein JL, Stein GS.

J Cell Physiol. 2019 Jun;234(6):8597-8609. doi: 10.1002/jcp.27841. Epub 2018 Dec 4. Review.

PMID:
30515788
3.

Nuclear organization mediates cancer-compromised genetic and epigenetic control.

Zaidi SK, Fritz AJ, Tracy KM, Gordon JA, Tye CE, Boyd J, Van Wijnen AJ, Nickerson JA, Imbalzano AN, Lian JB, Stein JL, Stein GS.

Adv Biol Regul. 2018 Aug;69:1-10. doi: 10.1016/j.jbior.2018.05.001. Epub 2018 May 9. Review.

4.

Regulation of osteogenesis by long noncoding RNAs: An epigenetic mechanism contributing to bone formation.

Tye CE, Boyd JR, Page NA, Falcone MM, Stein JL, Stein GS, Lian JB.

Connect Tissue Res. 2018 Dec;59(sup1):35-41. doi: 10.1080/03008207.2017.1412432.

PMID:
29745821
5.

Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer.

Tracy KM, Tye CE, Ghule PN, Malaby HLH, Stumpff J, Stein JL, Stein GS, Lian JB.

Mol Cancer Res. 2018 Apr;16(4):587-598. doi: 10.1158/1541-7786.MCR-17-0548. Epub 2018 Jan 29.

6.

Intranuclear and higher-order chromatin organization of the major histone gene cluster in breast cancer.

Fritz AJ, Ghule PN, Boyd JR, Tye CE, Page NA, Hong D, Shirley DJ, Weinheimer AS, Barutcu AR, Gerrard DL, Frietze S, van Wijnen AJ, Zaidi SK, Imbalzano AN, Lian JB, Stein JL, Stein GS.

J Cell Physiol. 2018 Feb;233(2):1278-1290. doi: 10.1002/jcp.25996. Epub 2017 Jun 22.

7.

Selective expression of long non-coding RNAs in a breast cancer cell progression model.

Tracy KM, Tye CE, Page NA, Fritz AJ, Stein JL, Lian JB, Stein GS.

J Cell Physiol. 2018 Feb;233(2):1291-1299. doi: 10.1002/jcp.25997. Epub 2017 Jun 15.

8.

Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition.

Hong D, Messier TL, Tye CE, Dobson JR, Fritz AJ, Sikora KR, Browne G, Stein JL, Lian JB, Stein GS.

Oncotarget. 2017 Mar 14;8(11):17610-17627. doi: 10.18632/oncotarget.15381.

9.

Oncogenic epigenetic control.

Stein GS, Messier TL, Gordon JA, Boyd JR, Tye CE, Lian JB, Stein JL.

Aging (Albany NY). 2016 Apr;8(4):565-6. doi: 10.18632/aging.100940. No abstract available.

10.

Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.

Messier TL, Gordon JA, Boyd JR, Tye CE, Browne G, Stein JL, Lian JB, Stein GS.

Oncotarget. 2016 Feb 2;7(5):5094-109. doi: 10.18632/oncotarget.6922.

11.

Chromatin interaction analysis reveals changes in small chromosome and telomere clustering between epithelial and breast cancer cells.

Barutcu AR, Lajoie BR, McCord RP, Tye CE, Hong D, Messier TL, Browne G, van Wijnen AJ, Lian JB, Stein JL, Dekker J, Imbalzano AN, Stein GS.

Genome Biol. 2015 Sep 28;16:214. doi: 10.1186/s13059-015-0768-0.

12.

Non-coding RNAs: Epigenetic regulators of bone development and homeostasis.

Hassan MQ, Tye CE, Stein GS, Lian JB.

Bone. 2015 Dec;81:746-756. doi: 10.1016/j.bone.2015.05.026. Epub 2015 May 31. Review.

13.

p38α MAPK is required for tooth morphogenesis and enamel secretion.

Greenblatt MB, Kim JM, Oh H, Park KH, Choo MK, Sano Y, Tye CE, Skobe Z, Davis RJ, Park JM, Bei M, Glimcher LH, Shim JH.

J Biol Chem. 2015 Jan 2;290(1):284-95. doi: 10.1074/jbc.M114.599274. Epub 2014 Nov 18.

14.

Could lncRNAs be the missing links in control of mesenchymal stem cell differentiation?

Tye CE, Gordon JA, Martin-Buley LA, Stein JL, Lian JB, Stein GS.

J Cell Physiol. 2015 Mar;230(3):526-34. doi: 10.1002/jcp.24834. Review.

15.

Matrix metalloproteinase-20 over-expression is detrimental to enamel development: a Mus musculus model.

Shin M, Hu Y, Tye CE, Guan X, Deagle CC, Antone JV, Smith CE, Simmer JP, Bartlett JD.

PLoS One. 2014 Jan 23;9(1):e86774. doi: 10.1371/journal.pone.0086774. eCollection 2014.

16.

Assessment of dental fluorosis in Mmp20 +/- mice.

Sharma R, Tye CE, Arun A, MacDonald D, Chatterjee A, Abrazinski T, Everett ET, Whitford GM, Bartlett JD.

J Dent Res. 2011 Jun;90(6):788-92. doi: 10.1177/0022034511398868. Epub 2011 Mar 8.

17.

Fluoride does not inhibit enamel protease activity.

Tye CE, Antone JV, Bartlett JD.

J Dent Res. 2011 Apr;90(4):489-94. doi: 10.1177/0022034510390043. Epub 2010 Nov 30.

18.

Altered ion-responsive gene expression in Mmp20 null mice.

Tye CE, Sharma R, Smith CE, Bartlett JD.

J Dent Res. 2010 Dec;89(12):1421-6. doi: 10.1177/0022034510384625. Epub 2010 Oct 7.

19.

Targeted p120-catenin ablation disrupts dental enamel development.

Bartlett JD, Dobeck JM, Tye CE, Perez-Moreno M, Stokes N, Reynolds AB, Fuchs E, Skobe Z.

PLoS One. 2010 Sep 16;5(9). pii: e12703. doi: 10.1371/journal.pone.0012703.

20.

Phosphorylation of Ser136 is critical for potent bone sialoprotein-mediated nucleation of hydroxyapatite crystals.

Baht GS, O'Young J, Borovina A, Chen H, Tye CE, Karttunen M, Lajoie GA, Hunter GK, Goldberg HA.

Biochem J. 2010 May 27;428(3):385-95. doi: 10.1042/BJ20091864.

PMID:
20377527
21.

DPPI may activate KLK4 during enamel formation.

Tye CE, Pham CT, Simmer JP, Bartlett JD.

J Dent Res. 2009 Apr;88(4):323-7. doi: 10.1177/0022034509334240.

22.

Transforming growth factor-beta1 expression is up-regulated in maturation-stage enamel organ and may induce ameloblast apoptosis.

Tsuchiya M, Sharma R, Tye CE, Sugiyama T, Bartlett JD.

Eur J Oral Sci. 2009 Apr;117(2):105-12. doi: 10.1111/j.1600-0722.2009.00612.x.

23.

XBP1 may determine the size of the ameloblast endoplasmic reticulum.

Tsuchiya M, Tye CE, Sharma R, Smith CE, Bartlett JD.

J Dent Res. 2008 Nov;87(11):1058-62.

24.

Lysosomal protease expression in mature enamel.

Tye CE, Lorenz RL, Bartlett JD.

Cells Tissues Organs. 2009;189(1-4):111-4. doi: 10.1159/000151431. Epub 2008 Aug 15.

25.

Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro.

Gordon JA, Tye CE, Sampaio AV, Underhill TM, Hunter GK, Goldberg HA.

Bone. 2007 Sep;41(3):462-73. Epub 2007 May 6.

PMID:
17572166
26.

Origin, splicing, and expression of rodent amelogenin exon 8.

Bartlett JD, Ball RL, Kawai T, Tye CE, Tsuchiya M, Simmer JP.

J Dent Res. 2006 Oct;85(10):894-9.

27.

In vivo functional analysis of polyglutamic acid domains in recombinant bone sialoprotein.

Wazen RM, Tye CE, Goldberg HA, Hunter GK, Smith CE, Nanci A.

J Histochem Cytochem. 2007 Jan;55(1):35-42. Epub 2006 Sep 6.

PMID:
16957163
28.

Identification of the type I collagen-binding domain of bone sialoprotein and characterization of the mechanism of interaction.

Tye CE, Hunter GK, Goldberg HA.

J Biol Chem. 2005 Apr 8;280(14):13487-92. Epub 2005 Feb 8.

29.

Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein.

Tye CE, Rattray KR, Warner KJ, Gordon JA, Sodek J, Hunter GK, Goldberg HA.

J Biol Chem. 2003 Mar 7;278(10):7949-55. Epub 2002 Dec 18.

30.
31.

Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesis.

Harris NL, Rattray KR, Tye CE, Underhill TM, Somerman MJ, D'Errico JA, Chambers AF, Hunter GK, Goldberg HA.

Bone. 2000 Dec;27(6):795-802.

PMID:
11113390

Supplemental Content

Support Center